InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,644.19
(
0.17%
)
US TECH 100
19,172.80
(
-0.14%
)
Dow Jones
41,341.79
(
0.40%
)
Brent Oil
80.54
(
2.76%
)
Bitcoin
63,548.07
(
-1.27%
)
Post# of 252973
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 82187

Tuesday, 10/27/2009 12:57:15 PM

Tuesday, October 27, 2009 12:57:15 PM

Post# of 252973
GSK/Genmab announced the accelerated approval of Arzerra (ofatumumab) from the FDA for use in patients with chronic lymphocytic leukemia (CLL) that is refractory to fludarabine and alemtuzumab.

http://www.reuters.com/article/marketsNews/idCNLR34044920091027?rpc=44
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up